GlassScriptPhysician profile
Angela Kondo
NPI 1033755053
$647.00
in general payments reported to CMS, 2019-2025
10 companies · $37.61 in 2025
The $37.61 reported for 2025 was less than what a typical Psychiatric/Mental Health (Nurse Practitioner) provider received nationally (typical 2025 total: $257).
See the full distribution for Psychiatric/Mental Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $275 · 2023: $259 · 2024: $75.54 · 2025: $37.61.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $351 · Education: $21.12.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $350.60 |
| Education | $21.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $182.60 | 2022-2024 | |
| Janssen Biotech, INC. | $136.01 | 2022 | |
| Ucb, INC. | $135.13 | 2022-2023 | Cimzia |
| E.R. Squibb & Sons, L.L.C. | $37.61 | 2025 | Cobenfy |
| Amgen INC. | $37.07 | 2022 | |
| Lilly USA, LLC | $33.19 | 2023 | Taltz |
| Kiniksa Pharmaceuticals, LTD. | $25.87 | 2023 | Arcalyst |
| Radius Health, INC. | $21.97 | 2022 | |
| Celltrion USA INC. | $21.12 | 2023 | Yuflyma |
| Pfizer INC. | $16.43 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Angela Kondo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.